Cell cycle regulation and induction of apoptosis by IL-6 variants on the multiple myeloma cell line XG-1

Annals of Hematology

Volumn 78, Issue 1, 1999, Pages 13-18

  Petrucci, M T ^a   Ricciardi, M R ^a   Ariola, C ^a   Gregorj, C ^a   Ribersani, M ^a   Savino, R ^b   Ciliberto, G ^b   Tafuri, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRBM   (Italy)

Author keywords

Apoptosis; Cell cycle; Cell line; IL 6 variants; Multiple myeloma

Indexed keywords

ACRIDINE ORANGE; BETA ACTIN; CELL DNA; CYCLIN D1; DNA NUCLEOTIDYLEXOTRANSFERASE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MUTANT PROTEIN; REGULATOR PROTEIN; RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL KINETICS; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

APOPTOSIS; CELL CYCLE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-6; MULTIPLE MYELOMA; TUMOR CELLS, CULTURED;

EID: 0033001902     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050465     Document Type: Article

References (24)

1. Anderson KC, Joncs RM, Morimoto C, Leavitt P, Barut BA (1989) Response patterns of purified myeloma cells to hematopoietic growth factors. Blood 73:1915-1924
2. Andreeff M, Assing G, Cirrincione C (1984) Prognostic value of DNA/RNA flow cytometry in myeloblastic and lymphoblastic leukemia in adults: RNA content and S-phase predict remission duration and survival in multivariate analysis. Ann NY Acad Sci 468:387-406
3. Bataille R, Barlogie B, Yang Lu Z, Rossi J-F, Lavabre-Bertrand T, Beck T, Wijdenes J, Brochier J, Klein B (1995) Biological effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood 86:685-691
4. Darzynkiewicz Z, Evenson DP, Staiano-Coico L, Sharpless T, Melamed MR (1979) Relationship between RNA content and progression of lymphocytes through the S phase of the cell cycle. Proc Natl Acad Sci U S A 76:358-362
5. Demartis A, Bernassola F, Savino R, Melino G, Ciliberto G (1996) Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death. Cancer Res 56:4213-4218
6. Dolbeare F, Beisker W, Pallavicini MG, Vanderlaan M, Gray JW (1985) Cytochemistry for bromodeoxyuridine/DNA analysis: stoichiometry and sensitivity. Cytometry 6:521-526
7. Durie BGM (1986) Staging and kinetics of multiple myeloma. Semin Oncol 13:300-309
8. Gorczyca W, Bruno S, Darzynkiewicz R, Gong J, Darzynkiewicz, Z (1992) DNA strand breaks occurring during apoplosis: their early in situ detection by the terminal deoxy-nucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncol 1:1-10
9. Hardin J, MacLeod S, Grigorieva I, Chang R, Barlogie B, Xiao H, Epstein J (1994) Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood 84:3063-3070
10. Hata H, Xiao X, Petrucci MT, Woodliff J, Chang R, Epstein J (1993) Interleukin-6 gene expression in multiple myeloma: a characteristic of immune tumor cells. Blood 81:3357-3364
11. Kawano M, Hirano T, Matsuda T, Tags T, Horii Y, Iwato K, Asaoku H, Tang B, Tanahe O, Tanaka H, Kuramoto A, Kishimoto T (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332:83-85
12. Klein B, Zhang X, Jourdan M, Content J, Houssiau F, Aarden L, Piechaczyk M, Battaille R (1989) Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73:517-526
13. Lemoli RM, Tafuri A, Fortuna A, Petrucci MT, Ricciardi MR, Catani L, Rondelli D, Fogli M, Leopardi G, Ariola C, Tura S (1997) Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood 89:1189-1196
14. Pagano M, Pepperkok J, Lukas J, Baldin V, Ansorge W, Bartek J, Draetta G (1993) Regulation of human cell cycle by the cdk2 protein kinase. J Cell Biol 121:101-111
15. Savino R, Lahm A, Salvati AL, Ciapponi L, Sporeno E, Altamura S, Paonessa G, Toniatti C, Ciliberto G (1994) Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp 130 activation. EMBO J 13:1357-1367
16. Savino R, Ciapponi L, Lahm A, Demartis A, Cabibbo A, Toniatti C, Delmastro P, Altamura S, Ciliberto G (1994) Rational design of a receptor super-antagonist of human interleukin-6. EMBO J 13:5863-5870
17. Savino R, Demartis A, Ciapponi L, Cabibbo A, Toniatti C, Ciliberto G (1997) The receptor super-antagonist Sant7:a potent and safe inhibitor of IL-6 on human myeloma cells (review). Oncol Rep 4:485-492
18. Sporeno E, Savino R, Ciapponi L, Paonessa G, Cabibbo A, Lahm A, Pulkki K, Sun RX, Toniatti C, Klein B, Ciliberto G (1996) Human IL-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells. Blood 87:4510-4519
19. Tafuri A, Andreeff M (1990) Kinetic rationale for cytosine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro. Leukemia 4:826-834
20. Taga T, Kawanishi Y, Hardy RR, Hirano T, Kishimoto T (1987) Receptors for B cell stimulatory factor 2. J Exp Med 166:967-981
21. Towbin H, Staehlin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76:4350-4354
22. Vink A, Coulie P, Warnier G (1990) Mouse plasmacytomas growth in vivo: enhancement by interleukin-6 (1L-6) and inhibition by antibodies directed against IL-6 or its receptor. J Exp Med 172:997-1002
23. Zhang XG, Klein B, Bataille R (1989) Interleukin-6 is a potent myeloma cell growth factor in patients with aggressive multiple myeloma. Blood 74:11-13
24. Zhang X-G, Gaillard JP, Robillard N, Lu Z-Y, Gu Z-J, Jourdan M, Boiron JM, Battaille R, Klein B (1994) Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 83:3654-3663